Bibliographic Details
| Title: |
Point-of-Care Tests for HIV Drug Resistance Monitoring: Advances and Potentials. |
| Authors: |
Chua, Rayeil J., Capiña, Rupert, Ji, Hezhao |
| Source: |
Pathogens; Jul2022, Vol. 11 Issue 7, pN.PAG-N.PAG, 12p |
| Subject Terms: |
ANTI-HIV agents, DRUG resistance, DRUG monitoring, ANTIRETROVIRAL agents, TURNAROUND time |
| Abstract: |
HIV/AIDS is a global public health crisis that is yet to be contained. Effective management of HIV drug resistance (HIVDR) supported by close resistance monitoring is essential in achieving the WHO 95-95-95 targets, aiming to end the AIDS epidemic by 2030. Point-of-care tests (POCT) enable decentralized HIVDR testing with a short turnaround time and minimal instrumental requirement, allowing timely initiation of effective antiretroviral therapy (ART) and regimen adjustment as needed. HIVDR POCT is of particular significance in an era when ART access is scaling up at a global level and enhanced HIVDR monitoring is urgently needed, especially for low-to-middle-income countries. This article provides an overview of the currently available technologies that have been applied or potentially used in HIVDR POCT. It may also benefit the continued research and development efforts toward more innovative HIVDR diagnostics. [ABSTRACT FROM AUTHOR] |
|
Copyright of Pathogens is the property of MDPI and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.) |
| Database: |
Complementary Index |
